The most frequently reported adverse effects of GLP-1 receptor agonists are gastrointestinal in nature
Nearly three million people in the United States suffer from seizures, making it an all-too familiar occurrence in our society today
The weight loss achieved varies by medication: liraglutide typically produces 5-8% weight loss, semaglutide approximately 15%, and tirzepatide up to 21% of initial body weight
Rojas Lopez RF, Lynett Barrera D, Amaya Muoz MC, Saavedra Diaz MP
There was an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, nephrolithiasis, interstitial nephritis and drug-induced pancreatitis associated with GLP-1RA use compared to usual care
Ben Horowitz doesnt sugarcoat startup life